论文部分内容阅读
氯化亚铊(~(201)Tl)注射液是诊断心肌梗塞、缺血等症的性能优越、获得广泛应用的放射性药物。一些发达国家均已相继试制成功,并大量生产以满足临床的需要。我所放射性氯化亚铊(~(201)Tl)注射液研制组利用本所回旋加速器所产生的30MV质子辐照天然铊靶而获得~(201)Tl。其核反应为:
Thallium chloride (~ (201) Tl) injection is the diagnosis of myocardial infarction, ischemic embolism superior performance, widely used radiopharmaceuticals. Some developed countries have successfully trial-produced, and mass-produced to meet clinical needs. Our radioactive thallium chloride (~ (201) Tl) injection group obtained ~ (201) Tl by irradiating the natural thallium target with 30MV protons produced by our cyclotron. The nuclear reaction is: